How to Get Jatenzo in Louisiana

What Is Jatenzo and Why Does Oral Delivery Matter

Jatenzo is the only FDA-approved oral testosterone undecanoate capsule available in the United States. Approved in March 2019, it bypasses first-pass hepatic metabolism by absorbing through intestinal lymphatics rather than the portal vein, which is the mechanism that made earlier oral testosterone products hepatotoxic. 1

The key registration trial, Swerdloff et al. (J Clin Endocrinol Metab 2020, N=166 men with primary or secondary hypogonadism), found that 87% of subjects achieved an average serum testosterone concentration (C-avg) within the normal range of 300 to 1 to 000 ng/dL over a 24-hour dosing interval at steady state. 2 Mean C-avg was 504 ng/dL. That trial also documented the key cardiovascular signal: systolic blood pressure rose a mean of 3.9 mmHg from baseline, which drove the FDA to require a Risk Evaluation and Mitigation Strategy (REMS) program for the product. 3

For Louisiana men who dislike injections, find transdermal gels messy, or have transfer-to-partner concerns, oral dosing twice daily with a meal offers a practical option. The trade-off is cost and the blood pressure monitoring requirement.

Jatenzo is indicated specifically for conditions associated with a deficiency or absence of endogenous testosterone: primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired). Off-label use in transgender men or for age-related decline without confirmed lab-based hypogonadism is not approved. The American Urological Association's 2018 guideline on testosterone deficiency defines biochemical confirmation as two morning total testosterone measurements below 300 ng/dL on separate occasions. 4

Louisiana Telehealth Rules That Affect Your Jatenzo Prescription

Louisiana permits telehealth prescribing of controlled substances under specific conditions, and testosterone is a Schedule III controlled substance under federal law and Louisiana R.S. 40:964. 5 That classification means a prescriber must comply with both the federal Ryan Haight Online Pharmacy Consumer Protection Act and Louisiana's Telehealth Practice Act (La. R.S. 40:1223.1 et seq.).

Post-COVID, the DEA extended pandemic-era telemedicine flexibilities multiple times, most recently through December 31, 2025, allowing a first-time controlled substance prescription via audio-video telehealth without a prior in-person visit, provided the practitioner holds a DEA registration valid for Louisiana and has conducted a real-time audio-visual evaluation. 6 Once those temporary rules expire or change, an in-person evaluation may again be required before a Schedule III medication can be prescribed.

Practically, this means a Louisiana patient can schedule a telehealth visit today, complete a live video consultation with a licensed prescriber, have morning testosterone labs drawn at a local LabCorp or Quest, and receive an electronic prescription sent to a pharmacy with Jatenzo in stock. The prescriber must be actively licensed in Louisiana. Out-of-state providers holding only their home-state license cannot prescribe to Louisiana residents.

The Louisiana State Board of Medical Examiners and the Louisiana State Board of Nursing both require prescribers to establish a valid patient-provider relationship before issuing any prescription. A questionnaire alone does not satisfy that standard. A synchronous video visit does.

Labs Required Before a Louisiana Doctor Will Prescribe Jatenzo

Prescribers following evidence-based testosterone prescribing guidelines require a specific panel before writing the first Jatenzo prescription. The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy recommends confirming hypogonadism with at least two low morning testosterone measurements and concurrent luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels to distinguish primary from secondary hypogonadism. 7

The guideline states: "We recommend confirming the diagnosis by repeating the measurement of testosterone and including measurement of LH and FSH to classify the disorder." 7

Beyond testosterone and gonadotropins, most prescribers also order:

• Hematocrit and hemoglobin (baseline; Jatenzo raises hematocrit; the FDA label instructs holding therapy if hematocrit exceeds 54%) 1
• Prostate-specific antigen (PSA) in men over 40, per AUA guideline recommendations 4
• Comprehensive metabolic panel (CMP) to assess hepatic and renal function
• Lipid panel, because testosterone therapy modestly lowers HDL cholesterol 8
• Blood pressure measurement at every visit given the REMS blood pressure concern 1

Louisiana Quest and LabCorp locations process these panels within 24 to 72 hours for most patients. A telehealth provider can order the labs electronically before the prescription visit, so results are ready at the time of the clinical discussion.

The HealthRX clinical team uses a three-gate framework for Jatenzo initiation in Louisiana patients:

Gate 1 (Biochemical): Two morning total testosterone values <300 ng/dL drawn before 10 a.m., with LH/FSH confirming the hypogonadism subtype.

Gate 2 (Safety Screen): Hematocrit <50%, PSA <4.0 ng/mL (or stable with urologist sign-off if 2.5 to 4.0), systolic BP <150 mmHg, and no active prostate or breast cancer.

Gate 3 (Counseling Confirmation): Patient understands the twice-daily-with-food dosing requirement, blood pressure monitoring schedule, and the need for follow-up labs at weeks 3 to 5 after initiation.

Only patients clearing all three gates receive a prescription at the initial visit.

How Jatenzo Dosing Works After Your Prescription Is Filled

The FDA-approved starting dose is 237 mg (one capsule) twice daily, taken with food. Fat content in the meal enhances lymphatic absorption. The prescribing information states that a low-fat meal reduces the C-max by roughly 31% compared with a high-fat meal, so patients should aim for at least a moderate-fat meal with each dose. 1

At 3 to 5 weeks, the prescriber orders a serum testosterone level drawn 3 to 5 hours after the morning dose to approximate the C-avg. If the level falls below 400 ng/dL, the dose increases to 316 mg (one 237 mg capsule plus one 79 mg capsule) twice daily. If it exceeds 800 ng/dL, the dose decreases to 158 mg (one capsule) twice daily. Each titration step requires a repeat lab assessment 3 to 5 weeks later.

Blood pressure should be checked at every clinical encounter. For patients who develop hypertension on Jatenzo, the American Heart Association's 2017 guideline threshold of 130/80 mmHg applies. 9 Prescribers may initiate antihypertensive therapy, reduce the Jatenzo dose, or discontinue if BP cannot be controlled.

The Swerdloff trial reported no serious hepatotoxicity events across 166 participants over 52 weeks, consistent with the lymphatic absorption mechanism. 2 Liver function tests are not required on a scheduled basis per the label, though many clinicians obtain them at baseline.

Finding a Louisiana Doctor or Telehealth Provider to Prescribe Jatenzo

Louisiana has approximately 450 practicing urologists, endocrinologists, and men's health specialists who routinely manage testosterone deficiency. For patients in rural parishes, telehealth substantially expands access.

When evaluating a telehealth provider for Jatenzo in Louisiana, confirm:

1. The prescriber holds an active Louisiana medical license (verify at the Louisiana State Board of Medical Examiners license lookup at lsbme.la.gov).
2. The prescriber holds a DEA Schedule III registration.
3. The platform conducts a synchronous video visit, not a questionnaire-only model.
4. Follow-up labs and BP monitoring are built into the care plan, not optional add-ons.

Physician assistants and nurse practitioners in Louisiana may prescribe Schedule III controlled substances under a valid collaborative practice agreement (CPA) with a supervising or collaborating physician per La. R.S. 37:913 and La. R.S. 37:1360.22. A nurse practitioner prescribing Jatenzo in Louisiana must hold a CPA naming a collaborating physician, and that physician must be available for consultation. The patient has the right to verify this arrangement.

HealthRX providers serving Louisiana hold active Louisiana licenses and DEA registrations, conduct audio-video visits, and provide lab order integration with Quest Diagnostics locations across Baton Rouge, New Orleans, Shreveport, and Lafayette.

Jatenzo Pharmacies in Louisiana: Where to Fill Your Prescription

Jatenzo is a brand-name specialty product manufactured by Tolmar Pharmaceuticals. Retail pharmacies with specialty pharmacy capabilities can stock or order it within one to three business days. National chains including CVS Specialty, Walgreens, and Walmart Specialty Pharmacy can fill Jatenzo with a valid Louisiana prescription. Independent compounding pharmacies operating under 503A status in Louisiana can compound alternative testosterone formulations (capsules, creams, injectables), but they cannot legally dispense or substitute for FDA-approved Jatenzo itself.

If your commercial insurer covers Jatenzo, the prescription must go to an in-network specialty pharmacy. Most insurers require the pharmacy to be accredited by URAC or ACHC.

For cash-pay patients, Tolmar offers a Jatenzo savings card program. Retail cash price for a 30-day supply at 237 mg twice daily runs approximately $600 to $750 at Louisiana pharmacies as of early 2025. GoodRx and similar discount programs may reduce this by 15 to 25%.

Mail-order delivery to Louisiana from an out-of-state DEA-registered specialty pharmacy is legal, provided the dispensing pharmacy holds a Louisiana Non-Resident Pharmacy Permit issued by the Louisiana Board of Pharmacy. Patients should confirm this permit before having a prescription sent from an out-of-state mail-order facility.

Insurance Coverage and Prior Authorization in Louisiana

Louisiana Medicaid (Healthy Louisiana) does not cover Jatenzo for male hypogonadism as of 2025. Commercial insurance coverage varies widely. A 2019 analysis published in Translational Andrology and Urology found that prior authorization denial rates for testosterone products reach 20 to 30% on first submission, with appeals succeeding approximately 60% of the time when documentation is complete. 10

Most Louisiana commercial plans require the following documents for prior authorization:

• Two morning total testosterone lab results below 300 ng/dL on separate dates
• ICD-10 diagnosis code (E29.1 for primary testicular failure or E23.0 for hypopituitarism)
• Documentation that the patient has tried and failed, or has a clinical contraindication to, at least one lower-cost generic testosterone product (typically testosterone cypionate injection or a generic topical gel)
• Prescriber attestation that Jatenzo is medically necessary

The Endocrine Society guideline supports using the most cost-effective formulation when options exist, but also recognizes that injection-averse patients or those with documented skin reactions to topical products have a clinical basis for oral therapy. 7

If prior authorization is denied, the prescriber can file a peer-to-peer review request, typically within 30 days of denial. Louisiana law (La. R.S. 22:1839) requires health insurance issuers to respond to expedited prior authorization requests within 72 hours. Standard PA decisions must come within three business days for outpatient medications.

Transferring an Existing Jatenzo Prescription to Louisiana

Patients relocating to Louisiana with an active Jatenzo prescription from another state face a straightforward but time-sensitive process. Federal law and the Louisiana Board of Pharmacy rules allow a pharmacist to transfer a Schedule III prescription one time between pharmacies, provided both pharmacies are DEA-registered and the original prescription has valid refills remaining.

The original prescriber's Louisiana licensure is not required for a one-time transfer. However, once the transferred prescription is exhausted, a new prescription must come from a Louisiana-licensed provider. Patients should schedule a telehealth or in-person visit with a Louisiana prescriber before their transferred prescription runs out to avoid a gap in therapy.

Testosterone therapy interruption for more than two weeks can result in a return of hypogonadal symptoms. A cross-sectional study in the Journal of Sexual Medicine found that men discontinuing testosterone therapy reported significant worsening of fatigue, libido, and mood within two to four weeks of stopping. 11 Continuity planning matters.

Monitoring Schedule After Starting Jatenzo in Louisiana

Once on a stable Jatenzo dose, patients should follow the monitoring schedule consistent with the Endocrine Society's 2018 guideline: 7

• 3 to 5 weeks after initiation or dose change: Serum testosterone (3 to 5 hours post-morning dose), hematocrit, blood pressure
• 6 months after achieving stable dose: Repeat testosterone, hematocrit, PSA (men over 40), blood pressure
• Annually thereafter: Full panel including testosterone, hematocrit, PSA, lipids, blood pressure, and symptom assessment using a validated tool such as the Androgen Deficiency in Aging Males (ADAM) questionnaire or the Aging Males' Symptoms (AMS) scale 12

The FDA label for Jatenzo specifically instructs providers to withhold the medication and evaluate the cause if hematocrit exceeds 54%. 1 Erythrocytosis is the most common laboratory abnormality on testosterone therapy overall; the estimated incidence is 7 to 15% across testosterone formulations in the first 12 months. 13

Telehealth follow-up visits are billable in Louisiana under state telehealth parity law (La. R.S. 40:1223.3), which requires commercial insurers to reimburse telehealth services at the same rate as equivalent in-person services. This parity applies to follow-up testosterone management visits with lab review.

Cost Reduction Strategies for Louisiana Patients

Four concrete options exist for Louisiana patients paying cash or facing high copays:

1. Tolmar patient assistance program. Tolmar offers free or reduced-cost Jatenzo to uninsured or underinsured patients who meet income criteria. Applications are available at jatenzo.com or through the prescriber's office.

2. GoodRx or RxSaver coupons. These discount platforms negotiate reduced pharmacy rates and can lower cash price at Louisiana retail pharmacies by 15 to 30%.

3. 503A compounding. Louisiana-licensed 503A compounding pharmacies can prepare testosterone undecanoate capsules compounded to equivalent doses. Compounded testosterone undecanoate is not FDA-approved and lacks the clinical trial data of brand Jatenzo, but cost may be 60 to 80% lower. The FDA has noted that compounded testosterone products are not interchangeable with approved products. 14

4. Insurance appeal. A successful PA appeal converts cash-pay cost to a copay, typically $40 to $100 per month on commercial plans with pharmacy benefit coverage for specialty tiers.

Testosterone cypionate injection (generic) costs roughly $25 to $50 per month at Louisiana pharmacies. Insurers and Medicaid cover it broadly. Patients who primarily prefer oral dosing for convenience should weigh this cost differential against that preference with their prescriber.

Step-by-Step: Getting Jatenzo in Louisiana Today

1. Order morning testosterone labs (total testosterone, LH, FSH, hematocrit, PSA if over 40) at a local LabCorp or Quest. No physician order is required for self-pay direct lab testing in Louisiana.
2. Schedule a telehealth visit with a Louisiana-licensed prescriber, ensuring the visit is synchronous video.
3. At the visit, provide both low testosterone lab results. The prescriber will also measure or request blood pressure documentation.
4. If prescribed, confirm your pharmacy holds a Louisiana dispensing permit if using mail order, or choose a local specialty pharmacy.
5. Start Jatenzo at 237 mg twice daily with meals.
6. Return for labs at weeks 3 to 5 to confirm C-avg and hematocrit.
7. Verify your commercial insurance PA status within 72 hours of prescription submission to avoid delay.

Patients in Baton Rouge, New Orleans, Shreveport, Lafayette, and Lake Charles all have local Quest and LabCorp draw sites within 10 to 20 miles, making step one achievable same-day in most cases.